Scalable adherent cell processing for research and manufacturing
CellRev is an innovator in bioprocessing. We provide breakthrough solutions to enable cost effective and altogether more scalable manufacturing of cell-based vaccines, therapies, and drugs.
Our products leverage our application specific IP to address significant bottlenecks in cell culture protocols including aggregation, clumping, and process translatability. We support our customers to take novel treatments from discovery to manufacturing.
Our media additives permit productivity and cost improvements in existing batch, fed-batch, and perfusion based bioprocesses.
CellRev also offer a pioneering continuous processing platform for adherent cells, the Livit ACE. The invent of this platform represents one of the most meaningful breakthroughs in adherent cell processing for decades.
Whether developing a new process or improving an existing one, CellRev can provide tailored support to unlock your bioprocess.
Get in touch at enquiry@cellrev.co.uk to discuss how we can help you.
Bioprocessing, Adherent Cell Culture, Process Engineering, Cell Biology, Cell Growth, and High-Density Processing
CellRev’s continuous cell processing platform offers seamless translation from research to market with superior automation and control.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Other 14 Feb 2024 | | |
Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Capitalistic Not partnership Not event 9 Feb 2021 | | |
FoodHack Software Development | FoodHack Software Development | Other 21 Feb 2024 | |